Patents by Inventor Mark William Kroll

Mark William Kroll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9675799
    Abstract: The present invention relates, generally, to scientific and medical system methods for diagnosis of implantable cardioverter defibrillator (ICD) lead conductor anomalies, in particular conductor migration and externalization within an ICD implantable cardiac lead. The method uses an “imaginary” component of the high frequency transmission line impedance having certain spectral changes that correspond to movements of the conductor or an “imaginary impedance”. This allows the detection of conductor migration and small insulation failures.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: June 13, 2017
    Assignee: Lambda Nu Technology LLC
    Inventors: Mark William Kroll, Charles Dennis Swerdlow
  • Patent number: 9272150
    Abstract: The invention relates to a method and apparatus for diagnosis of conductor anomalies, such as insulation failures, in an implantable medical device, such as an implantable cardioverter defibrillator (ICD), a pacemaker, or a neurostimulator. Insulation failures are detected and localized by identifying changes in electrical fields via surface (skin) potentials. Small variations in potential are detected along the course of the electrode near the site of insulation failure.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: March 1, 2016
    Assignee: Lambda Nu Technology LLC
    Inventors: Mark William Kroll, Charles Dennis Swerdlow
  • Patent number: 8812103
    Abstract: Disclosed is a method for the diagnosis of conductor anomalies, such as an insulation failure resulting in a short circuit, in an implantable medical device, such as an implantable cardioverter defibrillator (ICD). Upon determining if a specific defibrillation pathway is shorted, the method excludes the one electrode from the defibrillation circuit, delivering defibrillation current only between functioning defibrillation electrodes. Protection can be provided against a short in the right-ventricular coil-CAN defibrillation pathway of a pectoral, transvenous ICD with a dual-coil defibrillation lead. If a short caused by an in-pocket abrasion is present, the CAN is excluded from the defibrillation circuit, delivering defibrillation current only between the right-ventricular and superior vena cava defibrillation coils. Determination that the defibrillation pathway is shorted may be made by conventional low current measurements or delivery of high current extremely short test pulses.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: August 19, 2014
    Assignee: Lamda Nu, LLC
    Inventors: Mark William Kroll, Charles Dennis Swerdlow
  • Publication number: 20140155947
    Abstract: The present invention relates, generally, to scientific and medical system methods for diagnosis of implantable cardioverter defibrillator (ICD) lead conductor anomalies, in particular conductor migration and externalization within an ICD implantable cardiac lead. The method uses an “imaginary” component of the high frequency transmission line impedance having certain spectral changes that correspond to movements of the conductor or an “imaginary impedance”. This allows the detection of conductor migration and small insulation failures.
    Type: Application
    Filed: March 15, 2013
    Publication date: June 5, 2014
    Inventors: Mark William Kroll, Charles Dennis Swerdlow
  • Patent number: 8718759
    Abstract: A multi-modal electrotherapy apparatus including circuitry for administering defibrillation therapy and for administering medium voltage therapy (MVT). A combined-use capacitor bank of at least one capacitor stores energy to be administered as defibrillation therapy and MVT. Combined-use discharge circuitry electrically is coupled between the combined-use capacitor bank and patient terminals for selectively administering energy from the capacitor bank according to a plurality of controllable waveforms as either defibrillation therapy or MVT. A controller is configured to cause the discharge circuitry to apply the MVT from the capacitor bank while the capacitor bank undergoes charging in preparation for administration of the defibrillation therapy.
    Type: Grant
    Filed: August 6, 2012
    Date of Patent: May 6, 2014
    Assignee: Galvani Ltd.
    Inventor: Mark William Kroll
  • Publication number: 20130325080
    Abstract: Disclosed is a method for the diagnosis of conductor anomalies, such as an insulation failure resulting in a short circuit, in an implantable medical device, such as an implantable cardioverter defibrillator (ICD). Upon determining if a specific defibrillation pathway is shorted, the method excludes the one electrode from the defibrillation circuit, delivering defibrillation current only between functioning defibrillation electrodes. Protection can be provided against a short in the right-ventricular coil-CAN defibrillation pathway of a pectoral, transvenous ICD with a dual-coil defibrillation lead. If a short caused by an in-pocket abrasion is present, the CAN is excluded from the defibrillation circuit, delivering defibrillation current only between the right-ventricular and superior vena cava defibrillation coils. Determination that the defibrillation pathway is shorted may be made by conventional low current measurements or delivery of high current extremely short test pulses.
    Type: Application
    Filed: March 15, 2013
    Publication date: December 5, 2013
    Inventors: MARK WILLIAM KROLL, Charles Dennis Swerdlow
  • Publication number: 20130325079
    Abstract: The invention relates to a method and apparatus for diagnosis of conductor anomalies, such as insulation failures, in an implantable medical device, such as an implantable cardioverter defibrillator (ICD), a pacemaker, or a neurostimulator. Insulation failures are detected and localized by identifying changes in electrical fields via surface (skin) potentials. Small variations in potential are detected along the course of the electrode near the site of insulation failure.
    Type: Application
    Filed: March 15, 2013
    Publication date: December 5, 2013
    Inventors: Mark William Kroll, Charles Dennis Swerdlow
  • Publication number: 20130035735
    Abstract: A multi-modal electrotherapy apparatus including circuitry for administering defibrillation therapy and for administering medium voltage therapy (MVT). A combined-use capacitor bank of at least one capacitor stores energy to be administered as defibrillation therapy and MVT. Combined-use discharge circuitry electrically is coupled between the combined-use capacitor bank and patient terminals for selectively administering energy from the capacitor bank according to a plurality of controllable waveforms as either defibrillation therapy or MVT. A controller is configured to cause the discharge circuitry to apply the MVT from the capacitor bank while the capacitor bank undergoes charging in preparation for administration of the defibrillation therapy.
    Type: Application
    Filed: August 6, 2012
    Publication date: February 7, 2013
    Inventor: Mark William Kroll
  • Patent number: 6062474
    Abstract: A method is taught for analyzing the keystroke timing signature of an ATM or other electronic commerce customer. The timing signature is compared to a database of previously stored keystroke timing sequences to allow for a test of the identity of the putative customer. This allows increased identification without the need for additional hardware beyond the ubiquitous keypad or keyboard.
    Type: Grant
    Filed: October 2, 1997
    Date of Patent: May 16, 2000
    Inventor: Mark William Kroll